Literature DB >> 11085505

Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma.

K Langlands1, G A Down, T Kealey.   

Abstract

Helix-loop-helix genes regulate many developmental pathways, and growing evidence associates dysregulated expression with tumorigenesis. We observed Id-1, Id-2, and Id-3 mRNA expression in proliferating human keratinocytes in vitro with subsequent down-regulation with differentiation. Immunohistochemical analysis of human tissue sections identified cytoplasmic Id-1 expression and nuclear Id-2 and Id-3 expression in the proliferating layers of the epidermis. Furthermore, we observed a columnar pattern of Id-2 and Id-3 staining, which may relate to the epidermal proliferative unit. In squamous cell carcinoma of the head and neck, Id protein immunoreactivity was observed in the majority of malignant keratinocytes in the most poorly differentiated sections, with reduced staining in well-differentiated disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085505

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Transcriptional control of epidermal specification and differentiation.

Authors:  Xing Dai; Julia A Segre
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

2.  Identification of Id1 in acquired middle ear cholesteatoma.

Authors:  Quan-An Zhang; Yuki Hamajima; Qing Zhang; Jizhen Lin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-03

3.  High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

Authors:  Aaron M Elliott; Kristi A Hohenstein Elliott; Anja Kammesheidt
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

4.  MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes.

Authors:  Mohammed I Ahmed; Andrei N Mardaryev; Christopher J Lewis; Andrey A Sharov; Natalia V Botchkareva
Journal:  J Cell Sci       Date:  2011-10-07       Impact factor: 5.285

5.  Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Authors:  Silvia Coma; Dhara N Amin; Akio Shimizu; Anna Lasorella; Antonio Iavarone; Michael Klagsbrun
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

6.  Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways.

Authors:  Jizhen Lin; Zhong Guan; Chuan Wang; Ling Feng; Yiqing Zheng; Emiro Caicedo; Ellalane Bearth; Jie-Ren Peng; Patrick Gaffney; Frank G Ondrey
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

7.  Differential expression of multiple genes in association with MADH4/DPC4/SMAD4 inactivation in pancreatic cancer.

Authors:  Dengfeng Cao; Raheela Ashfaq; Michael G Goggins; Ralph H Hruban; Scott E Kern; Christine A Iacobuzio-Donahue
Journal:  Int J Clin Exp Pathol       Date:  2008-04-10

8.  Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation.

Authors:  Olga Golonzhka; Xiaobo Liang; Nadia Messaddeq; Jean-Marc Bornert; Adam L Campbell; Daniel Metzger; Pierre Chambon; Gitali Ganguli-Indra; Mark Leid; Arup K Indra
Journal:  J Invest Dermatol       Date:  2008-12-18       Impact factor: 8.551

9.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Authors:  Sylvia Fong; Yoko Itahana; Tomoki Sumida; Jarnail Singh; Jean-Philippe Coppe; Yong Liu; Peter C Richards; James L Bennington; Nancy M Lee; Robert J Debs; Pierre-Yves Desprez
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

10.  Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas.

Authors:  Liang Shan; Minshu Yu; Cunping Qiu; Elizabeth G Snyderwine
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.